InMode Ltd introduces the Morpheus8 Body Multi-pulse Burst Radiofrequency Vulcanization Technology.

Expanding on the recent launch of the Morpheus8 Body Subdermal Adipose Remodeling Device (SARD), the FDA-cleared technology to penetrate tissue with a thermal profile of 8mm, comes Morpheus8 Body Burst Technology. The fractional technology automatically deploys bipolar RF energy to multi-level treatment depths in a single cycle. 

The ability to target tissue sequentially at three levels, in millisecond intervals, helps reduce treatment times, minimizes skin injury, increases treatment uniformity, and enables customized full body fractional procedures, the company explains in a media release.

“Morpheus8 Burst RF technology was predicated on the principles of the Vulcanization Process for cross linking rubber molecules to improve elasticity and tensile strength.

“Burst mode mediated RF Vulcanization involves a 3-step process, forming cross links between long collagen fiber molecules in a stratified depth range, to brace the Fibro Septal Network (FSN) and ultimately strengthen the overall skin-adipose scaffold. We are very proud to bring this unprecedented, highly efficacious modality to RF fractional treatments.”

— Dr Spero Theodorou, InMode Chief Medical Officer

“With the recent launch of Morpheus8 Body, InMode pioneered full body fractional treatments. The subsequent commercialization of Morpheus8 Burst with multi-level energy deployment unequivocally solidifies InMode as the fractional market leader. Our robust innovation pipeline continues to redefine the medical aesthetics industry and further differentiates InMode as the frontrunner for delivering leading-edge treatment solutions.”

— InMode President of North America, Shakil Lakhani

[Source(s): InMode Ltd, PR Newswire]